Common Contracts
7 similar Severance and Change in Control Agreement contracts by Corcept Therapeutics Inc
AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 31st, 2009 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
THIS AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of September 19, 2008 (the “Effective Date”) is entered into by and between Joseph K. Belanoff, MD, Chief Executive Officer (“Executive”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 31st, 2009 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
THIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of November 28, 2008 (the “Effective Date”) is entered into by and between Caroline Loewy, Chief Financial Officer (“Executive”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 31st, 2009 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
THIS AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of September 19, 2008 (the “Effective Date”) is entered into by and between Anne M. LeDoux, Vice President and Controller (“Executive”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 31st, 2009 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
THIS AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of September 19, 2008 (the “Effective Date”) is entered into by and between Robert L. Roe, MD, President (“Executive”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • August 14th, 2007 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
THIS CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of July 24, 2007 (the “Effective Date”) is entered into by and between Joseph K. Belanoff, M.D., Chief Executive Officer, (“Executive”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • August 14th, 2007 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
THIS CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of July 24, 2007 (the “Effective Date”) is entered into by and between Robert L. Roe, M. D., President, (“Executive”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • August 14th, 2007 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
THIS CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of July 24, 2007 (the “Effective Date”) is entered into by and between Anne M. LeDoux, Vice President and Chief Accounting Officer, (“Executive”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
